Exhibit 107
CALCULATION OF FILING FEE TABLES
FORM S-1
ABVC BioPharma, Inc.
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule (1) | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee (3) | ||||||||||||||||||||
| Equity | Common Stock, $0.001 par value, issuable upon exercise of the Lind Warrant | 457(c) | 1,000,000 | $ | 0.85 | (2) | $ | 850,000 | 0.00014760 | $ | 125.46 | ||||||||||||||||
| Total Offering Amounts | 1,000,000 | $ | 0.00014760 | $ | 125.46 | ||||||||||||||||||||||
| Total Fees Previously Paid | $ | - | |||||||||||||||||||||||||
| Total Fee Offsets | $ | - | |||||||||||||||||||||||||
| Net Fee Due | $ | 125.46 | |||||||||||||||||||||||||
| (1) | Pursuant to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares as may from time to time become issuable by reason of stock splits, distributions, recapitalizations or other similar transactions. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act. The proposed maximum offering price per share is estimated to be $0.85, based on the average of the high ($0.869) and low ($0.830) sales prices of the Common Stock as reported by the Nasdaq Capital Market on June 14, 2024. |
| (3) | The fee is calculated by multiplying the aggregate offering amount by 0.00014760 pursuant to Section 6(b) of the Securities Act. |
